The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers
Clinical trial NCT00718666 · COMPLETED
Trial details
- NCT number
- NCT00718666
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-20
- Primary completion
- 2013-11-13
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.